小檗碱通过调节肠道菌群改善牙周骨丢失
本研究在卵巢切除(OVX)联合实验性牙周炎的大鼠模型中,给予小檗碱治疗7周。结果显示小檗碱显著减少牙槽骨丢失、改善骨代谢,并提高产丁酸肠道菌群丰度、增强肠道屏障完整性、降低血清内毒素和IL-17A相关炎症反应。提示肠道菌群是治疗雌激素缺乏加重牙周骨丢失的潜在靶点,小檗碱是有前景的辅助治疗。
要点
- 小檗碱显著减少OVX牙周炎大鼠的牙槽骨丢失并改善骨代谢。
- 小檗碱提高产丁酸菌丰度、增强肠道屏障、降低血清内毒素。
- 小檗碱减轻IL-17A相关免疫反应和全身炎症。
核心结论
- 肠道菌群是治疗雌激素缺乏加重牙周骨丢失的潜在靶点。
- 小檗碱通过调节肠道菌群成为有前景的辅助治疗。
研究设计与样本
- 在卵巢切除(OVX)大鼠中建立实验性牙周炎模型。
- OVX-牙周炎大鼠接受小檗碱治疗7周后处死分析。
- 对照为载体治疗的OVX-牙周炎大鼠。
主要发现
- 小檗碱治疗显著减少OVX-牙周炎大鼠的牙槽骨丢失并改善骨代谢。
- 小檗碱治疗组产丁酸肠道菌群丰度更高且丁酸生成增加。
- 小檗碱治疗组肠道屏障完整性改善、细胞旁通透性降低、血清内毒素水平降低。
- 小檗碱治疗组IL-17A相关免疫反应减弱,血清促炎细胞因子水平降低,牙槽骨中IL-17A+细胞减少。
临床怎么用
- 小檗碱可能作为雌激素缺乏相关牙周骨丢失的辅助治疗。
- 调节肠道菌群可作为牙周炎伴骨质疏松患者的潜在干预方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Postmenopausal osteoporosis (PMO) is a risk factor for periodontitis, and current therapeutics against PMO prevent the aggravated alveolar bone loss of periodontitis in estrogen-deficient women. Gut microbiota is recognized as a promising therapeutic target for PMO. Berberine extracted from Chinese medicinal plants has shown its effectiveness in the treatment of metabolic diseases such as obesity and diabetes via regulating gut microbiota. Here, we hypothesize that berberine ameliorates periodontal bone loss by improving the intestinal barriers by regulating gut microbiota under an estrogen-deficient condition. Experimental periodontitis was established in ovariectomized (OVX) rats, and the OVX-periodontitis rats were treated with berberine for 7 wk before sacrifice for analyses. Micro-computed tomography and histologic analyses showed that berberine treatment significantly reduced alveolar bone loss and improved bone metabolism of OVX-periodontitis rats as compared with the vehicle-treated OVX-periodontitis rats. In parallel, berberine-treated OVX-periodontitis rats harbored a higher abundance of butyrate-producing gut microbiota with elevated butyrate generation, as demonstrated by 16S rRNA sequencing and high-performance liquid chromatography analysis. Berberine-treated OVX-periodontitis rats consistently showed improved intestinal barrier integrity and decreased intestinal paracellular permeability with a lower level of serum endotoxin. In parallel, IL-17A-related immune responses were attenuated in berberine-treated OVX-periodontitis rats with a lower serum level of proinflammatory cytokines and reduced IL-17A+ cells in alveolar bone as compared with vehicle-treated OVX-periodontitis rats. Our data indicate that gut microbiota is a potential target for the treatment of estrogen deficiency-aggravated periodontal bone loss, and berberine represents a promising adjuvant therapeutic by modulating gut microbiota.
引用
- Jia X, Jia L, Mo L, et al. Berberine Ameliorates Periodontal Bone Loss by Regulating Gut Microbiota. J Dent Res. 2018. PMID: 30199654. doi:10.1177/0022034518797275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。